NICO Corporation is progressing corridor surgery by creating instruments that allow for access through smaller openings and resection of soft tissue abnormalities. NICO’s goal is to develop new technology for corridor surgery in market segments including ENT, Spinal, Cranial and Otolaryngology that comprise approximately 500,000 procedures in the U.S. annually and 2.3 million worldwide.

NICO devices are cleared by the FDA for the following uses: NICO Myriad “for the morcellation and removal of tissue during pelviscopic, laparoscopic, percutaneous and open surgical procedures whenever access to the surgical site is limited.” NICO BrainPath “provides for access and allows for visualization of the surgical field during brain and spinal surgery.” NICO Myriad and BrainPath are “tools” and are not “treatments”. These devices have been used by physicians to address soft tissue abnormalities. This webpage discusses a sampling of ways physicians have employed NICO technology. NICO Myriad and BrainPath are not intended to treat, cure, prevent, mitigate or diagnose any specific cranial, ENT, Spinal or Otolaryngologic disease, including cancer or stroke. Physicians should use their best judgment and clinical experience when deciding where to use NICO Myriad and BrainPath. Full prescribing information for the NICO Myriad and BrainPath is available on the products page of this website.